How Olivia Munn’s doctor knew she was at risk for breast cancer

Deborah Farr, M.D. is a surgical oncologist who specializes in treating breast cancer. When Dr. Farr heard about Olivia Munn’s diagnosis, she immediately knew what tool gave her the lifesaving information that she needed. “The breast cancer risk assessment tool…

¿La soja aumenta el riesgo de cáncer de mama?

Ha generado varios debates. ¿Hay alguna conexión entre la soja y el cáncer de mama? La soja contiene isoflavonas, que son los estrógenos vegetales. Se han relacionado los niveles altos de estrógeno con un mayor riesgo de cáncer de mama. Sin embargo, hay estudios que demuestran que los productos de soja no contienen niveles de estrógeno lo suficientemente altos como para aumentar las probabilidades de desarrollar cáncer de mama.

Launch of a pioneering translational research programme in Europe

– The TRIP initiative establishes three new joint laboratories that bring together fundamental biomedical research and clinical research with the aim of accelerating the delivery of results to patients.
– TRIP will focus on emerging fields such as immuno-oncology, inflammation, and cellular senescence.

NCCN Updates Treatment Recommendations for Breast, Colorectal, Lung, and other Cancer Types Based on Emerging Evidence

Recent NCCN Guidelines updates—along with the supporting evidence—will be presented during the NCCN 2024 Annual Conference held in Orlando, Florida April 5-7, and simultaneously online. Visit NCCN.org/conference to learn more and register.

Study Underscores Social Factors of Low Breast Cancer Screening in the U.S.

To identify major social factors hindering breast cancer screening in U.S. women aged 40 and older, researchers focused on race/ethnicity, employment, education, food security, insurance status, housing and access to quality health care. Access to health care emerged as a statistically significant theme (61 percent) and insurance status was the most reported sub-categorical factor. Language was the third highest issue, highlighting its significance as an influential factor of screening behavior. Race/ethnicity, sex/gender and sexual orientation were additional factors reported.

National Breast Cancer Foundation Gives Grant to Help Breast Care Center Patients at Texas Tech Physicians of El Paso

In addition to assisting with access to care, such as transportation and general needs like groceries, the grant will allow the Breast Care Center to screen for mental and emotional distress using tablets. Currently, patients participate in an online distress screening survey that prompts questions about financial and psychosocial stressors in a patient’s life.

Re-excision rates after breast-conserving surgery pose ongoing challenges in the US: UTHealth Houston study unveils high reoperation rates and costs

Rates of re-excision after initial breast-conserving surgery in women with breast cancer remain high across the United States, leading to an increased cost of care and a higher risk of postoperative complications, according to new research from UTHealth Houston.

New Research in JNCCN Suggests a Simple and Inexpensive Option for Reducing a Major Chemotherapy Side-Effect

New research in the November 2023 issue of JNCCN—Journal of the National Comprehensive Cancer Network suggests that breast cancer patients who have insufficient levels of vitamin D before starting paclitaxel treatment are more likely to experience peripheral neuropathy.

New NUS study provides insights into early breast cancer development in individuals with BRCA2 mutations

A pioneering study led by the Cancer Science Institute of Singapore (CSI Singapore) at the National University of Singapore and the University of Cambridge (UK) has uncovered vital insights into the distinct effects of BRCA2 mutations on breast tissue cells, shedding light on early breast cancer development in people with BRCA2 mutations.

New Study Shows Insurance Coverage Disruptions Affect Key Cancer Screenings for U.S. Adults

A new study by researchers at the American Cancer Society shows that adults in the United States with prior insurance coverage disruptions are significantly less likely to receive guideline-concordant and past-year cancer screening, compared to people with continuous coverage.

Reliable Patient Education Materials on Breast Cancer Are Difficult to Access

Women with breast cancer must often make complex decisions about surgery and treatment options during an already stressful time in their lives, and many of these women may turn to the wide variety of materials available online. New research presented at the American College of Surgeons (ACS) Clinical Congress 2023 has found that reliable educational materials about breast surgery are not only difficult to assess but are also presented at much higher reading levels than recommended.

A Cancer Survival Calculator Is Being Developed Using Artificial Intelligence

Researchers have developed an artificial intelligence (AI)–based tool for estimating a newly diagnosed cancer patient’s chances for surviving long term, according to a study presented at the American College of Surgeons (ACS) Clinical Congress 2023.

Can Lifestyle Interventions Benefit Patients With Advanced Breast Cancer?

Can exercise, intermittent fasting and other lifestyle changes help patients with advanced breast cancer better tolerate side effects from treatment? A new $4-million NCI-funded study at Sylvester Comprehensive Cancer Center seeks to answer that question.

MD Anderson Research Highlights: ESMO 2023 Special Edition

This special edition features upcoming oral presentations by MD Anderson researchers at the 2023 European Society for Medical Oncology (ESMO) Congress focused on clinical advances across a variety of cancer types.

Inflammatory Breast Cancer: Know the Risks and Warning Signs of This Rare, Fast-Growing Cancer

Inflammatory breast cancer is a rare type of breast cancer. It only accounts for one to five percent of all breast cancer cases, but it’s important to know your risk and the warning signs, as this form of the disease is aggressive, fast-growing, and hard to detect early. For October, during Breast Cancer Awareness Month, the American Cancer Society is highlighting IBC to help women be aware of this invasive cancer.

MD Anderson launches collaborative initiative to reduce breast cancer disparities in Houston area

The University of Texas MD Anderson Cancer Center launches a community-wide health care initiative to reduce breast cancer disparities in the Houston area, particularly for Black women. Texas Health Equity Alliance for Breast Cancer (THEAL), seeks to lower the Black/white breast cancer mortality gap in Harris County by 15% over the next decade.

MD Anderson Research Highlights for October 4, 2023

The University of Texas MD Anderson Cancer Center’s Research Highlights showcases the latest breakthroughs in cancer care, research and prevention. These advances are made possible through seamless collaboration between MD Anderson’s world-leading clinicians and scientists, bringing discoveries from the lab to the clinic and back. Recent developments at MD Anderson include a computer game that helps breast cancer survivors improve symptoms of peripheral neuropathy, a publicly available single-cell atlas of CD19 chimeric antigen receptor (CAR) T cells, new targets for TP53-mutant acute myeloid leukemia (AML), a preclinical target for preventing chemobrain, a blood test to help identify patients at higher risk of developing pancreatic cancer, and genomic insights to predict the risk of outcomes in patients with bone cancer.

Shorter course of radiation therapy is safe for patients with early-stage breast cancer who have undergone mastectomy and reconstruction

Researchers at Dana-Farber Brigham Cancer Center have found that a shorter course of radiation therapy after mastectomy and breast reconstruction surgery provides the same protection against breast cancer recurrence and equivalent physical side-effects but substantially reduces life disruption and financial burden for patients.

Short-course radiation as effective as standard treatment for patients who opt for breast reconstruction after mastectomy

In a first-of-its-kind study, people with breast cancer who underwent implant-based breast reconstruction immediately following a mastectomy reported that getting fewer, higher doses of radiation was just as effective as standard radiation, did not increase side effects and saved them time and money.

Palex and Inbiomotion introduce pioneering test to aid oncologists in predicting recurrence and survival rates in breast cancer patients

Spain is the first country in the world to have this technology
• Results showing the clinical utility of the test were published in
Lancet Oncology and the Journal of National Cancer Institute
• The test is now available to oncologists and pathologists and will
benefit an estimated 24,000 patients each year in Spain

Researchers at Case Western Reserve, University Hospitals to assess effectiveness of novel MRI method for breast cancer patients

Researchers at Case Western Reserve University
(CWRU) and University Hospitals (UH) will study whether a new magnetic resonance imaging exam can predict how chemotherapy’s effectiveness for a woman with breast cancer based on a single round of treatment.

Living Beyond Breast Cancer Provides Expert Patient Perspectives during Breast Cancer Awareness Month

This fall, Living Beyond Breast cancer, the national patient information and support organization, is providing expert patient perspectives on patients living with breast cancer. Connect with members of the LBBC community to discuss living with breast cancer, racial equity in breast cancer health, and body image and reconstruction.

Study Unlocks New Insight about Breast Cancer Risk

A new study led by a researcher at New York Institute of Technology provides insight that could change how scientists and clinicians understand genetic predisposition to breast cancer, a condition that affects one in eight U.S. women in her lifetime.

Cancer screenings have saved the U.S. at least $6.5 trillion, study estimates

Americans have gotten at least 12 million more years of life to live because of preventive cancer screenings they’ve gotten the past 25 years, a new study estimates. That adds up to at least $6.5 trillion in added economic impact, because of scans and tests that look for early signs of breast, colon, cervical and lung cancer in adults at the highest risk.